Literature DB >> 10656250

Identification of a novel aspartic protease (Asp 2) as beta-secretase.

I Hussain1, D Powell, D R Howlett, D G Tew, T D Meek, C Chapman, I S Gloger, K E Murphy, C D Southan, D M Ryan, T S Smith, D L Simmons, F S Walsh, C Dingwall, G Christie.   

Abstract

The Alzheimer's disease beta-amyloid peptide (Abeta) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of beta- and then gamma-secretases. Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of beta-secretase. Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-associated C-terminal beta-secretase APP fragment. Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the production of the fragments characteristic of cleavage at the beta-secretase site. The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Abeta. Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10656250     DOI: 10.1006/mcne.1999.0811

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  265 in total

1.  In search of gamma-secretase: presenilin at the cutting edge.

Authors:  D J Selkoe; M S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  A yeast genetic assay for caspase cleavage of the amyloid-beta precursor protein.

Authors:  P L Gunyuzlu; W H White; G L Davis; G F Hollis; J H Toyn
Journal:  Mol Biotechnol       Date:  2000-05       Impact factor: 2.695

Review 3.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

4.  Novel functional assay for proteases and modulators. Application in beta-secretase studies.

Authors:  Y Li; Y W Liu; B Cordell
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

Review 5.  Presenilin, Notch, and the genesis and treatment of Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

6.  BACE1 gene promoter single-nucleotide polymorphisms in Alzheimer's disease.

Authors:  Weihui Zhou; Fang Cai; Yu Li; George S Yang; Kathleen D O'Connor; Robert A Holt; Weihong Song
Journal:  J Mol Neurosci       Date:  2010-05-09       Impact factor: 3.444

7.  BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.

Authors:  M Farzan; C E Schnitzler; N Vasilieva; D Leung; H Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 8.  Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease.

Authors:  Vivian Hook; Gregory Hook; Mark Kindy
Journal:  Biol Chem       Date:  2010-08       Impact factor: 3.915

9.  Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.

Authors:  Jing Shi; Yunzhou Dong; Mei-Zhen Cui; Xuemin Xu
Journal:  Biochim Biophys Acta       Date:  2012-10-02

10.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.